» Articles » PMID: 37686712

The Influence of Ketogenic Diet on Gut Microbiota: Potential Benefits, Risks and Indications

Overview
Journal Nutrients
Date 2023 Sep 9
PMID 37686712
Authors
Affiliations
Soon will be listed here.
Abstract

The ketogenic diet (KD) restricts carbohydrate consumption, leading to an increase in ketone bodies, such as acetoacetate, β-hydroxybutyrate, and acetone, which are utilized as energy substrates. This dietary approach impacts several biochemical processes, resulting in improved clinical management of various disorders, particularly in childhood. However, the exact mechanisms underlying the efficacy of KD remain unclear. Interestingly, KD may also impact the gut microbiota, which plays a pivotal role in metabolism, nutrition, and the development of the immune and nervous systems. KD has gained popularity for its potential benefits in weight loss, blood sugar control, and certain neurological conditions. This narrative review sums up KD-related studies published over 30 years. While short-term studies have provided valuable insights into the effects of KD on the gut microbiota, persistent uncertainties surround its long-term efficacy and potential for inducing dysbiosis. The significant influence of KD on epigenetic mechanisms, intracellular pathways, and gut microbial composition underscores its potential as a therapeutic choice. However, a judicious consideration of the potential risks associated with the strict adherence to a low-carbohydrate, high-fat, and high-protein regimen over prolonged periods is imperative. As KDs gain popularity among the adolescent and young adult demographic for weight management, it becomes imperative to undertake additional research to comprehensively assess their impact on nutritional status and gut microbiota, ensuring a holistic and sustainable approach to medical nutrition.

Citing Articles

Unraveling the Connections: Eating Issues, Microbiome, and Gastrointestinal Symptoms in Autism Spectrum Disorder.

Tomaszek N, Urbaniak A, Baldyga D, Chwesiuk K, Modzelewski S, Waszkiewicz N Nutrients. 2025; 17(3).

PMID: 39940343 PMC: 11819948. DOI: 10.3390/nu17030486.


The Interplay Between Gut Microbiota, Adipose Tissue, and Migraine: A Narrative Review.

Biagioli V, Mela F, Ferraro P, Villano G, Orsini A, Diana M Nutrients. 2025; 17(2).

PMID: 39861467 PMC: 11768392. DOI: 10.3390/nu17020337.


Comprehensive Overview of Ketone Bodies in Cancer Metabolism: Mechanisms and Application.

Liang Z, Deng L, Zhou X, Zhang Z, Zhao W Biomedicines. 2025; 13(1).

PMID: 39857793 PMC: 11760447. DOI: 10.3390/biomedicines13010210.


Ketogenic diet and cancer: multidimensional exploration and research.

Wan S, Zhou X, Xie F, Zhou F, Zhang L Sci China Life Sci. 2025; .

PMID: 39821829 DOI: 10.1007/s11427-023-2637-2.


Effects of the Ketogenic Diet on Microbiota Composition and Short-Chain Fatty Acids in Women with Overweight/Obesity.

Guzey Akansel M, Bas M, Gencalp C, Kahriman M, Sahin E, Ozturk H Nutrients. 2025; 16(24.

PMID: 39770995 PMC: 11679786. DOI: 10.3390/nu16244374.


References
1.
Calderon N, Betancourt L, Hernandez L, Rada P . A ketogenic diet modifies glutamate, gamma-aminobutyric acid and agmatine levels in the hippocampus of rats: A microdialysis study. Neurosci Lett. 2017; 642:158-162. DOI: 10.1016/j.neulet.2017.02.014. View

2.
Simm P, Bicknell-Royle J, Lawrie J, Nation J, Draffin K, Stewart K . The effect of the ketogenic diet on the developing skeleton. Epilepsy Res. 2017; 136:62-66. DOI: 10.1016/j.eplepsyres.2017.07.014. View

3.
Lucas S, Omata Y, Hofmann J, Bottcher M, Iljazovic A, Sarter K . Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat Commun. 2018; 9(1):55. PMC: 5754356. DOI: 10.1038/s41467-017-02490-4. View

4.
Tyagi A . Mechanism of action of gut microbiota and probiotic Lactobacillus rhamnosus GG on skeletal remodeling in mice. Endocrinol Diabetes Metab. 2023; 7(1):e440. PMC: 10782069. DOI: 10.1002/edm2.440. View

5.
Hopkins B, Pauli C, Du X, Wang D, Li X, Wu D . Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature. 2018; 560(7719):499-503. PMC: 6197057. DOI: 10.1038/s41586-018-0343-4. View